10:30 am Navigating the Path to the First MASH Therapeutic Approval & Progressing Beyond to Advance Clinical Development Strategies to Expand the Horizon of Approved Drugs
Time: 10:30 am
day: Conf day 2
Details:
- Delving into the strategic clinical development and trial design methodologies that led to the unprecedented first therapeutic approval in MASH, setting a crucial benchmark for future candidates
- Reviewing the comprehensive clinical data and real-world evidence to demonstrate the significant efficacy and safety profiles that underpin the treatment’s success and inform optimal patient management
- Exploring how lessons learned from Madrigal’s development journey, alongside ongoing research, are influencing the design of subsequent clinical trials and accelerating the pipeline for next-generation MASH therapies
